Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Heparin in COVID-19 Patients
NCT05255848Phase 3Unknown
- Start
- Jun 2022
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in COVID-19 pneumonia. Status: unknown.
02
Drugs
heparin
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05255848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05255848.